Regional differences in the early mucosal immune response induced by primary inoculation of mice with respiratory syncytial virus

Microbial Pathogenesis

Volumn 36, Issue 3, 2004, Pages 141-146

  Hishiki, Haruka ^a,c   Zuercher, Adrian W ^b,d   Valosky, Janine ^a   Coffin, Susan E ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Berna Biotech AG   (Switzerland)

Author keywords

Antibodies; Immunity; Respiratory syncytial virus; Respiratory tract; Viral infections

Indexed keywords

IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CERVICAL LYMPH NODE; CONTROLLED STUDY; IMMUNE RESPONSE; INOCULATION; KINETICS; LYMPHOID TISSUE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; SYNCYTIAL VIRUS;

EID: 0347951065     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micpath.2003.10.007     Document Type: Article

References (37)

1. Garenne M., Ronsmans C., Campbell H. The magnitude of mortality from acute respiatory infections in children under 5 years in developing countries. World Health Stat Q. 45:1992;180-191.
2. Glezen W.P., Denny F.W. Epidemiology of acute lower respiratory tract disease in children in the pediatric group practice. J Pediatr. 78:1973;397-406.
3. Shay D.K., Holman R.C., Roosevelt G.E., Clarke M.J., Anderson L.J. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among U.S. children, 1979-1997. J Infect Dis. 183:2001;16-22.
4. Dudas R.A., Karron R.A. Respiratory syncytial virus vaccines. Clin Microbiol Rev. 11:1998;430-439.
5. Beem M. Repeated infections with respiratory syncytial virus. J Immunol. 98:1967;1115-1122.
6. Henderson F.W., Collier A.M., Clyde W.A., Denny F.W. Respiratory syncytial virus infections, reinfections, and immunity. New Engl J Med. 300:1979;530-534.
7. Hall C.B., Walsh E.E., Long C.E., Schnabel K.C. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis. 163:1991;693-698.
8. Graham B.S., Bunton L.A., Wright P.F., Karzon D.T. Reinfection of mice with respiratory syncytial virus. J Med Virol. 34:1991;7-13.
9. Groothuis J.R., Simoes E.A., Levin M.J., et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med. 329:1993;1524-1530.
10. Glezen W.P., Paredes A., Allison J.E., Taber L.H., Frank A.L. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 98:1981;708-715.
11. Anonymous. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV study group. Pediatrics. 102:1998;531-537.
12. Crowe J.E., Firestone C.Y., Murphy B.R. Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines. J Immunol. 167:2001;3910-3918.
13. Malley R., DeVincenzo J., Ramilo O., et al. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis. 178:1998;1555-1561.
14. Graham B.S., Tang Y.-W., Gruber W.C. Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin. J Infect Dis. 171:1995;1468-1474.
15. Zuercher A.W., Coffin S.E., Thurnheer M.C., Fundova P., Cebra J.J. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses. J Immunol. 168:2002;1796-1803.
16. Porgador A., Staats H.F., Itoh Y., Kelsall B.L. Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue. Infect Immun. 66:1998;5876-5881.
17. Asanuma H., Aizawa C., Kurata T., Tamura S. IgA antibody-forming cells responses in the nasal-assocaited lyumphoid tissue of mice vaccinated by intranasal, intravenous, and/or subcutaneous administration. Vaccine. 16:1998;1257-1262.
18. Tamura S., Iwasaki T., Thompson A.H., Asanuma H., Chen Z., Suzuki Y., Aizawa C., Kurata T. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection. J Gen Virol. 79:1998;291-299.
19. Balmelli C., Demotz S., Acha-Orbea H., DeGrandi P., Nardelli-Haefliger D. Trachea, lung, and tracheobronchial lymph nodes are the major sites were antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles. J Virol. 17:2002;12596-12602.
20. Wu H.-Y., Nikolova E.B., Beagley K.W., Russell M.W. Induction of antibody-secreting cells and memory cells in murine nasal lymphoid tissue. Immunology. 88:1996;493-500.
21. Asanuma H., Inaba Y., Aizawa C., Kurata T., Tamura S. Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase. J Immunol Meth. 187:1995;41-51.
22. Liang B., Hyland L., Hou S. Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice. J Virol. 75:2001;5416-5420.
23. Hameleers D.M.H., van der Ven I., Sminia T., Biewenga J. Anti-TNP-forming cells in rats after different routes of priming with TNP-LPS followed by intranasal boosting with the same antigen. Res Immunol. 141:1990;515-528.
24. Hameleers D.M.H., vander Ven I., Biewenga J., Sminia T. Mucosal and systemic antibody formation in the rat after intranasal administration of three different antigens. Immunol Cell Biol. 69:1991;119-125.
25. Heritage P.L., Underdown B.J., Arsenault A.L., Snider D.P., McDermott M.R. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. Am J Res Crit Care Med. 156:1997;1256-1262.
26. McIntyre T.M., Stober W. Gut-associated lymphoid tissue: regulation of IgA B-cell development. Ogra P.L., Mestecky J., Lamm M.E., Strober W., Bienenstock J., McGhee J.R. Mucosal immunology. 2nd ed :1999;319-356.
27. Asanuma H., Thompson A.H., Iwasaki T., et al. Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Meth. 202:1997;123-131.
28. Sangster M.Y., Mo X.Y., Sealy R., Coleclough C. Matching antibody class with pathogen type and portal of entry. J Immunol. 159:1997;1893-1902.
29. vanCott J.L., Brim T.A., Simkins R.A., Saif L.J. Isotype-specific antibody-secreting cells to transmissible gastroenteritis virus and porcine respiratory coronavirus in gut- and bronchus-associated lymphoid tissues of suckling pigs. J Immunol. 150:1993;3990-4000.
30. Coffin S.E., Clark S.L. Induction of intestinal rotavirus-specific antibodies in respiratory, but not gut, lymphoid tissues following mucosal immunization of mice with inactivated rotavirus. Virology. 291:2001;235-240.
31. Balmelli C., Robden R., Potts A., Schiller J., deGrandi P., Nardelli-Haefliger D. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. J Virol. 72:1998;8220-8229.
32. Wu H.-Y., Russell M.W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun. 61:1993;314-322.
33. Matsuo K., Iwasaki T., Asanuma H., et al. Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination. Vaccine. 18:2000;1344-1350.
34. Stack A.M., Malley R., Saladino R.A., Montana J.B., MacDonald K.L., Molrine D.C. Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model. Vaccine. 18:2000;1412-1418.
35. Logan A.C., Chow K.N., George A., Weinstein P.D., Cebra J.J. Use of Peyer's patch and lymph node cultures to compare local immune response to Morganella morganii. Infect Immun. 59:1991;1024-1030.
36. Graham B.S., Bunton L.A., Rowland J., Wright P.F., Karzon D.T. Respiratory syncytial virus infection in anti-μ-treated mice. J Virol. 65:1991;4936-4942.
37. Coffin S.E., Clark S.L., Bos N.A., Brubaker J.O., Offit P.A. Migration of antigen-presenting cell B cells from peripheral of mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization. J Immunol. 163:1999;3064-3070.